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ABSTRACT
An easy and convenient route for the synthesis of 2,4-substituted thiazine (3–6) and 2,5-substituted thiazole (16) derivatives from
phenacetamidines and glycine methyl ester is reported. To the best of our knowledge, this is the first report in which
phenacetamidines have been utilized as precursors for thiazine synthesis. The syntheses of novel cyclic fused
1,3-diazabutadienes 13 and 2-aza-1,3-butadiene 17, and iodocyclization of 17 leading to the formation of thiazole 16a are also
reported. In this paper a total of twenty novel compounds are reported.
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1. Introduction
Heterocycles containing nitrogen and sulphur atoms, for
instance thiazines, display diverse properties such as
antifungal,1 anti-HIV,2 antipsoratic3 and antimicrobial4 activities
and thus are of great chemical and pharmaceutical significance.5–14
Some benzodiazepine substitutes15 of imidazo[2,1-b]-[1,3]
thiazines and pyrimido[2,1-b]-[1,3] thiazines are well known
anti-inflammatory agents.16 Likewise, thiazoles have also been
reported to possess an important role in various fields of medicinal
and agricultural chemistry. For example, the thiazolium ring
present in vitamin B1 serves as an electron sink, and its coenzyme
form is important for the decarboxylation of α-keto acids.17 Some
aminothiazole analogues are used as fungicides, inhibit the
in vivo growth of Xanthomonas, and act as an ingredient of
herbicides or as schistosomicidal and anthelminitic drugs.
Fanetizole is also a derivative of 2-aminothiazole, which is used
as an anti-inflammatory agent.18 Owing to their immense
chemical and biological interest, a number of methods have
been reported for their synthesis and many of these suffer from
disadvantages such as complex experimental procedures6–8,11–13
and low isolated yields.19,20
As part of our ongoing interest in heterocyclic synthesis,21 we
wish to report herein an easy and convenient route for the
synthesis of thiazine and thiazole derivatives starting from
phenacetamidines and glycine methyl ester, respectively.
2. Results and Discussion
The treatment of phenylacetamidines 1 with potassium
tert-butoxide (4.2 eq) and carbon disulphide (2.2 eq) and subse-
quent alkylation with methyl/ethyl iodide (4.0 eq) in THF at 0 °C
resulted in the formation of 2-alkylsulphanyl-5-phenyl-4-N-
arylamino-[1,3] thiazine-6-thione derivatives 3 in good yields
(70–85 %) (Scheme 1). The structures assigned for 3 were based
on elemental analysis and spectroscopic data. 2-Methyl-
sulphanyl-5-phenyl-4-p-tolylamino-[1,3] thiazine-6-thione (3a),
for example, gave elemental analysis results matching the
formula C18H16N2S3. In the
1H NMR spectrum it shows a
characteristic singlet at δ 2.30 ppm for –CH3, a singlet at δ
2.44 ppm for –SCH3 along with multiplets in the aromatic region
at δ 7.06–7.59 ppm. A broad singlet at δ 6.56 ppm in the 1H NMR
spectrum indicates the presence of a –NH group, which was
confirmed further by a D2O exchange experiment. The structure
of the compound was also substantiated by its 13C spectrum,
which showed characteristic peaks at δ 14.4 (-SCH3), 20.8 (-CH3),
115.7 (=C-CS), 122.2 (CAr), 129.3 (CAr), 129.9 (CAr), 130.2 (CAr),
130.7 (CAr), 132.8 (CAr), 134.2 (C-Ar), 135.3 (-N-C-NH), 159.9
(-NH-C=), 160.6 (-C=N) and 167.3 ppm (-C=S). The presence of
a molecular ion peak at m/z 356 (M+) in its mass spectrum also
supports the assigned structure.
However, the same reaction when carried out under the
conditions described above but at –78 °C resulted in exclusive
formation of thiazines 5 (Scheme 1). These compounds were also
characterized on the basis of their spectroscopic data. For example,
the compound (2,6-bis-methylsulphanyl-5-phenyl-[1,3]
thiazin-4-ylidene)-p-tolylamine (5a) exhibits a molecular ion
peak at m/z 370 (M+) in its mass spectrum. Its IH NMR spectrum
showed three characteristic singlets at δ 2.28, 2.33 and 2.35 ppm,
corresponding to one –CH3 and two –SCH3 groups, respectively,
along with multiplets at δ 6.83–7.44 ppm for the nine deshielded
aromatic protons. The structure of 5a was further corroborated
by its 13C spectrum, which showed peaks at δ 13.9 (-SCH3), 16.1
(-SCH3), 21.0 (-CH3), 122.2 (CAr), 127.8 (CAr), 128.1 (CAr), 128.3
(CAr), 130.1 (CAr), 130.3 (CAr), 132.4 (CAr), 136.3 (ArC-CH3),
136.4 (S-C-S), 146.7 (=N-CAr), 150.2 (-S-C=N-) and 164.6 ppm
(-N-C=N).
The probable mechanism leading to formation of thiazine
derivatives 3 and 5 is outlined in Scheme 2. In this scheme, it is
assumed that the treatment of phenacetamidine with base and
carbon disulphide leads to the formation of an intermediate 7
which upon its alkylation and tautomerization transforms into
an intermediate 8. The intermediate 8 tautomerizes to another
intermediate 9 which, upon intramolecular cyclization by
nucleophilic attack of sulphur on the iminic carbon (-C=N),
eliminates the alkyl-thiol (-SR2) moiety resulting in the formation
of thiazines 3.
However, at –78 °C, the intermediate 9, probably being more
stable, undergoes further alkylation to form an intermediate 10
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which undergoes ring closure with removal of the alkyl thiol
moiety to form thiazines 5.
The thioalkyl (-SR2) group attached to the C=N bond of
thiazines 5 was replaced by aniline and some secondary amines
(morpholine and dimethylamine) in refluxing toluene to obtain
the corresponding imino-thiazines 6 (Scheme 1). Similarly, the
thioalkyl group of 3 was also replaced by morpholine in toluene
reflux (16–18 h) to obtain the corresponding morpholine substi-
tuted thiazines 4 (Scheme 1).
However, the treatment of phenacetamidines under similar
conditions, as discussed for 3, after alkylation with 1,3-dibromo-
propane (2.1 eq) led to the formation of cross-conjugated
systems 13 (Scheme 3). A plausible mechanistic pathway for this
reaction, depicted in Scheme 3, probably involves the initial
formation of an intermediate 11 which upon alkylation
transforms into an intermediate 12. The intermediate 12 under-
goes intramolecular cyclization by nucleophilic attack of sulphur
on the alkyl halide carbon (-CH2Br), being more facile and
approachable, than on iminic carbon (-C=N), leading to the
formation of compound 13.
As an extension of the above methodology, a solution of
glycine methyl ester 14 in DMF, when treated with carbon
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disulphide (1.1 eq) in the presence of sodium hydride (1.1 eq)
followed by alkylation with methyl iodide at 0 °C resulted in a
compound, characterized as methylsulphanylthiocarbonyl-
aminoacetic acid methyl ester 15 on the basis of spectral and
analytical data (Scheme 4).
Treatment of 14 with carbon disulphide (2.1 eq) in the presence
of sodium hydride (4.2 eq) at –20 °C and subsequent alkylation
with methyl/ethyl iodide (4.0 eq) resulted in a mixture consisting
predominantly of thiazoles 2,5-bis-methyl/ethylsulphanyl-
thiazole-4-carboxylic acid methyl ester 16 (62–68 %) and
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butadiene 17. Interestingly, the same reaction carried out at
–78 °C under the conditions described above led to the exclusive
formation of 17 (Scheme 4). The compound 17 could also be
easily converted to thiazole 16a by activation with I2 in refluxing
THF (Scheme 4). The observed single step and one pot conver-
sion of 14 to 16 is a significant improvement over the earlier
reported conversion of glycine ethyl ester to thiazoles22 in overall
yields of approximately 10 %. A plausible mechanistic pathway
for the formation of these compounds under varying reaction
conditions is depicted in Scheme 5.
The formation of 15 could be explained by the initial formation
of an intermediate 18, generated by the treatment of glycine
methyl ester 14 with CS2 using NaH, followed by methylation
with methyl iodide at 0 °C. The formation of 16 was thought to
involve the initial formation of an intermediate 19 obtained by
treatment of 14 with carbon disulphide (2.1 eq) using NaH
(4.2 eq), which upon alkylation with methyl/ethyl iodide (4.0 eq)
was transformed to another intermediate 21. The intermediate 21
upon elimination of a –SR group by the nucleophilic attack of
sulphur anion leads to the thiazoles 16 (Scheme 5). The exclusive
formation of 17 could be explained by the more favoured
alkylation at low temperature (–78 °C) compared with higher
temperature (0 °C), where intramolecular attack by S– on the
imino carbon also competes with the alkylation. The synthesis
of 16a from 17 may be explained by the initial iodination of a
–SCH3 group attached to C-1 leading to the formation of an
intermediate 20. This intermediate 20 on cyclization accompa-
nied by elimination of –CH3SI and R’I yields thiazole 16a
(Scheme 5).
Conclusions
An easy and efficient method for the synthesis of 1,3-thiazine
derivatives has been developed. To the best of our knowledge,
this is the first report in which phenacetamidines have been
utilized as precursors for thiazine synthesis. An easy access to
the synthesis of thiazoles from glycine methyl ester and novel
2-azadiene 17 has also been reported.
3. Experimental
3.1. General
Melting points were determined by open capillary using
Veego Precision Digital Melting Point apparatus (Mumbai,
India) and are uncorrected. IR spectra were recorded on a
Shimadzu (Shanghai, China) FTIR-8400S spectrophotometer.
1H NMR spectra were recorded in deuterochloroform with
Bruker (Geldermalsen, Netherlands) AC-E 200 (200 MHz)
spectrometers using TMS as internal standard. 13C NMR spectra
were also recorded on Bruker AC-E 200 (50.4 MHz) spectrometers
in deuterochloroform using TMS as internal standard. Mass
spectra were recorded on a Shimadzu (Shanghai, China)
GCMS-QP-2000 mass spectrometer. Elemental analyses were
performed on a Heraus CHN-O-Rapid Elemental Analyzer
(Hanau, Germany). Phenacetamidines were prepared according
to the reported procedure.23
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Scheme 5
3.2. General Procedure for the Synthesis of
1,3-Thiazines (3, 5 and 13)
To a suspension of potassium t-butoxide (42 mmol) in THF
(30 mL) at 0 °C was added a solution of phenacetamidine 1
(10 mmol) in THF (10 mL) and stirred for 10 min followed by the
addition of carbon disulphide (22 mmol). After stirring for 5 min
at the same temperature, alkyl halide (40 mmol) (methyl/ethyl
iodide for 3/1,3-dibromopropane for 13) was added to the reaction
mixture and stirring continued for 30 min. On completion
(monitiored by TLC), the reaction mixture was washed with
excess water (100 mL) and extracted using chloroform. The
crude product obtained after removal of the solvent under
reduced pressure was purified by silica gel column chromatog-
raphy. The compound, thus isolated, was recrystallized using a
hexane:ethyl acetate (10:1) mixture. The same reaction when
carried out under the conditions described above at –78 °C
resulted in exclusive formation of thiazines 5.
2-Methylsulphanyl-5-phenyl-4-p-tolylamino-[1,3] thiazine-
6-thione (3a)
From the reaction of 1a with carbon disulphide and methyl
iodide; eluent ethyl acetate:hexane mixture (5:95, Rf = 0.74 );
yield 67 %; yellow crystalline solid, m.p. 161–163 °C; δH
(300 MHz, CDCl3): 2.30 (s, 3H, -CH3), 2.44 (s, 3H, -SCH3), 6.56 (bs,
1H, -NH), 7.06 (d, J 8.2 Hz, 2H, ArH), 7.34–7.36 (m, 4H, ArH),
7.54–7.59 ppm (m, 3H, ArH); δC (75 MHz, CDCl3): 14.4 (-SCH3),
20.8 (-CH3), 115.7, 122.2, 129.3, 129.9, 130.2, 130.7, 132.8, 134.2,
135.3, 159.9, 160.6, 167.3 ppm; νmax (CHCl3): 1580, 1529, 1440 cm
–1;
m/z: 356 (M+). Found: C, 60.75; H, 4.47, N, 7.83 %. Calc. for
C18H16N2S3 (356); C, 60.64; H, 4.52, N, 7.86 %).
2-Methylsulphanyl-5-phenyl-4-phenylamino-[1,3] thiazine-
6-thione (3b)
From the reaction of 1b with carbon disulphide and methyl
iodide; eluent ethyl acetate:hexane mixture (6:94, Rf = 0.72 );
yield 65 %; light yellow crystalline solid; m.p. 145–147 °C; δH
(300 MHz, CDCl3): 2.45 (s, 3H, -SCH3), 6.54 (bs, 1H, -NH),
6.99–7.24 (m, 6H, ArH), 7.26–7.38 ppm (m, 4H, ArH); δC (75 MHz,
CDCl3): 14.4 (-SCH3), 114.9, 116.5, 121.8, 124.5, 129.8, 130.6, 133.4,
134.3, 135.3, 159.7, 160.3, 167.2 ppm; νmax (CHCl3): 1581, 1532,
1437 cm–1; m/z: 342 (M+). Found: C, 59.72; H, 4.07; N, 8.23 %. Calc.
for C17H14N2S3 (342); C, 59.61; H, 4.12; N, 8.18 %).
2-Ethylsulphanyl-5-phenyl-4-p-tolylamino-[1,3] thiazine-
6-thione (3c)
From the reaction of 1a with carbon disulphide and ethyl
iodide; eluent ethyl acetate:hexane mixture (5:95, Rf = 0.75 );
yield 66 %; yellow crystalline solid; m.p. 175–176 °C; δH
(300 MHz, CDCl3): 1.33 (t, J 7.4 Hz, 3H, -S-C-CH3), 2.30 (s, 3H,
-CH3), 2.99 (q, J 7.4 Hz, 2H, -SCH2), 6.59 (bs, 1H, -NH), 7.09 (d,
J 8.2 Hz, 2H, ArH), 7.32–7.36 (m, 5H, ArH), 7.55–7.61 ppm (m, 2H,
ArH); δC (75 MHz, CDCl3): 14.0 (-S-C-CH3), 20.8 (-CH3), 25.9
(-SCH2), 115.9, 122.2, 129.3, 129.8, 130.1, 130.7, 133.0, 134.2, 135.2,
159.8, 160.0, 167.2 ppm; νmax (CHCl3): 2972, 2923, 1583, 1531, 1440,
1215 cm–1; m/z: 370 (M+). Found: C, 61.77; H, 4.58; N, 7.63 %. Calc.
for C19H18N2S3 (370); C, 61.58; H, 4.90; N, 7.56 %).
2-Ethylsulphanyl-5-phenyl-4-phenylamino-[1,3] thiazine-
6-thione (3d)
From the reaction of 1b with carbon disulphide and ethyl
iodide; eluent ethyl acetate:hexane mixture (6:94, Rf = 0.71 );
yield 59 %; pale white solid; m.p. 166-168 °C; δH (300 MHz,
CDCl3): 1.32 (t, J 7.4 Hz, 3H, -S-C-CH3), 2.98 (q, J 7.4 Hz, 2H,
-SCH2), 6.58 (bs, 1H, -NH), 7.10–7.33 (m, 6H, ArH), 7.36–7.48 ppm
(m, 4H, ArH); δC (75 MHz, CDCl3): 14.1 (-S-C-CH3), 26.1 (-SCH2),
115.7, 121.4, 126.8, 129.6, 130.3, 130.9, 132.9, 134.5, 135.8, 158.4,
161.1, 167.1 ppm; νmax (CHCl3): 2924, 1584, 1502, 1441, 1215 cm
–1;
m/z: 356 (M+). Found: C, 60.77; H, 4.45; N, 7.78 %. Calc. for
C18H16N2S3 (356); C, 60.64; H, 4.52; N, 7.86 %).
(2,6-Bis-methylsulphanyl-5-phenyl-[1,3] thiazin-4-ylidene)-
p-tolylamine (5a)
From the reaction of 1a with carbon disulphide and methyl
iodide; eluent ethyl acetate:hexane mixture (8:92, Rf = 0.68 );
yield 69 %; yellow crystalline solid; m.p. 136-137 °C; δH (300 MHz,
CDCl3): 2.28 (s, 3H, -CH3), 2.33 (s, 3H, -SCH3), 2.35 (s, 3H, -SCH3),
6.83 (d, J 8.1 Hz, 2H, ArH), 7.02 (d, J 8.1 Hz, 2H, ArH),
7.31–7.44 ppm (m, 5H, ArH); δC (75 MHz, CDCl3): 13.9 (-SCH3),
16.1 (-SCH3), 21.0 (-CH3), 122.2, 127.8, 128.1, 128.3, 130.1, 130.3,
132.4, 136.3, 136.4, 146.7, 150.2, 164.6 ppm; νmax (CHCl3): 1571,
1552, 1523, 1440 cm–1; m/z: 370 (M+). Found: C, 61.69; H, 4.86;
N, 7.63 %. Calc. for C19H18N2S3 (370); C, 61.58; H, 4.90; N, 7.56 %).
(2,6-Bis-methylsulphanyl-5-phenyl-[1,3] thiazin-4-ylidene)-
phenylamine (5b)
From the reaction of 1b with carbon disulphide and methyl
iodide; eluent ethyl acetate:hexane mixture (10:90, Rf = 0.70);
yield 59 %; yellow solid; m.p. 157–158 °C; δH (300 MHz, CDCl3):
2.29 (s, 3H, -SCH3), 2.36 (s, 3H, -SCH3), 6.99–7.28 (m, 6H, ArH),
7.31–7.42 ppm (m, 4H, ArH); δC (75 MHz, CDCl3): 13.8 (-SCH3),
16.1 (-SCH3), 120.8, 126.7, 127.3, 128.2, 129.9, 131.1, 132.5, 135.9,
136.5, 144.9, 150.1, 164.5 ppm; νmax (CHCl3): 1570, 1551, 1440 cm
–1;
m/z: 356 (M+). Found: C, 60.79; H, 4.58; N, 7.73 %. Calc. for
C18H16N2S3 (356); C, 60.64; H, 4.52; N, 7.86 %).
2,N-Bis-[1,3] dithian-2-ylidene-2-phenyl-N’-p-tolyl-
acetamidine (13a)
From the reaction of 1a with carbon disulphide and 1,3-di-
bromopropane; eluent ethyl acetate:hexane mixture (12:88, Rf =
0.71); yield 51 %; light yellow solid; m.p. 122–123 °C; δH
(300 MHz, CDCl3): 1.93 ( q, J 6.6 Hz, 2H, -CH2), 2.12 (q, J 6.6 Hz, 2H,
-CH2), 2.27 (s, 3H, -CH3), 2.76 [(t, J 6.6 Hz, 4H, -SCH2)2], 2.92
[(t, J 6.6 Hz, 4H, -SCH2)2], 6.97 (d, J 8.2 Hz, 2H, ArH), 7.02 (d,
J 8.2 Hz, 2H, ArH), 7.25–7.33 ppm (m 5H, ArH); δC (75 MHz,
CDCl3): 20.9 (-CH3), 21.8, 23.9, 29.3, 29.8, 122.0, 127.5, 127.7, 128.6,
128.9, 130.3, 132.9, 138.1, 145.2, 147.4, 156.6, 166.1 ppm; νmax
(CHCl3): 1580, 1500, 1298 cm
–1; m/z: 456 (M+). Found: C, 60.58;




From the reaction of 1b with carbon disulphide and 1,3-
dibromopropane; eluent ethyl acetate:hexane mixture (10:90,
Rf = 0.65 ); yield 55 %; light yellow solid; m.p. 137–138 °C; δH
(300 MHz, CDCl3): 1.94 (q, J 6.6 Hz, 2H, -CH2), 2.11 (q, J 6.6 Hz, 2H,
-CH2), 2.72 [t, J 6.6 Hz, 4H, (-SCH2)2], 2.91 [t, J 6.6 Hz, 4H,
(-SCH2)2], 6.93–7.37 ppm (m, 10H, ArH); δC (75 MHz, CDCl3): 21.7,
23.5, 28.6, 29.6, 121.5, 125.6, 127.6, 128.5, 129.5, 131.5, 133.2, 137.6,
142.9, 147.3, 155.9, 166.2 ppm; νmax (CHCl3): 1582, 1500, 1298 cm
–1;
m/z: 442 (M+). Found: C, 59.59; H, 4.97; N, 6.41 %. Calc. for
C22H22N2S4 (442); C, 59.69; H, 5.01; N, 6.33%).
3.3. General Procedure for the Synthesis of Substituted
Thiazines 4 and 6
For synthesis of 4, a solution of thiazine 3 (10 mmol) in toluene
was refluxed along with morpholine (11 mmol) for 16–18 h. The
completion of the reaction was monitored by TLC. After comple-
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tion of the reaction, the solvent was evaporated under reduced
pressure and the crude product was purified through silica gel
column chromatography. The compounds thus obtained were
recrystallized using hexane:ethyl acetate (10:1) mixture.
For the synthesis of 6, a solution of thiazine 5 (10 mmol) and
primary/secondary amine (11 mmol) in toluene was refluxed
under a constant supply of ice-cooled water in a condenser, for a
period of 8–10 h. After completion (monitored by TLC), the
solvent was evaporated under reduced pressure and the crude




From the reaction of 3a with morpholine; eluent ethyl acetate:
hexane mixture (6:94, Rf = 0.69); yield 62 %; yellow solid; m.p.
164–165 °C; δH (300 MHz, CDCl3): 2.31 (s, 3H, -CH3), 3.56–3.61 (m,
4H, H2C-N-CH2), 3.62–3.66 (m, 4H, H2C-O-CH2), 6.58 (bs, 1H,
-NH), 6.84 (d, J 7.9 Hz, 2H, ArH), 6.99 (d, J 7.9 Hz, 2H, ArH),
7.19–7.42 ppm (m, 5H, ArH); δC (75 MHz, CDCl3): 21.1 (-CH3), 45.6
(-C-N-C-), 66.2 (-C-O-C-), 120.1, 121.9, 129.2, 130.5, 131.2, 131.6,
132.8, 134.5, 137.3, 158.7 161.5, 167.4 ppm; νmax (CHCl3): 2923,
1528, 1445, 1330, 1216, 1110 cm–1; m/z: 395 (M+). Found: C, 63.89;




From the reaction of 3b with morpholine; eluent ethyl acetate:
hexane mixture (8:92, Rf = 0.70); yield 67 %; yellow solid; m.p.
171–173 °C; δH (300 MHz, CDCl3): 3.55–3.60 (m, 4H, H2C-N-CH2),
3.62–3.67 (m, 4H, H2C-O-CH2), 6.59 (bs, 1H, -NH), 6.89–7.15 (m,
6H, ArH), 7.19–7.46 ppm (m, 4H, ArH); δC (75 MHz, CDCl3): 45.5
(-C-N-C-), 66.3 (-C-O-C-), 120.2, 122.1, 128.2, 130.3, 131.8, 132.0,
132.8, 134.7, 138.1, 157.9 161.7, 167.3 ppm; νmax (CHCl3): 2919,
1529, 1442, 1388, 1226 cm–1; m/z: 381 (M+). Found: C, 63.09;




From the reaction of 5a with morpholine; eluent ethyl acetate:
hexane mixture (5:95, Rf = 0.66 ); yield 71 %; yellow crystalline
solid; m.p. 141–142 °C; δH (300 MHz, CDCl3): 2.28 (s, 3H, -CH3),
2.33 (s, 3H, -SCH3), 3.57-3.60 (m, 4H, H2C-N-CH2), 3.67–3.69 (m,
4H, H2C-O-CH2), 6.80 (d, J 8.0 Hz, 2H, ArH), 6.97 (d, J 8.0 Hz, 2H,
ArH), 7.26–7.46 ppm (m, 5H, ArH); δC (75 MHz, CDCl3): 16.6
(-SCH3), 20.9 (-CH3), 45.7 (-C-N-C-), 66.2 (-C-O-C-), 122.2, 127.5,
127.9, 128.2, 130.1, 131.5, 132.0, 136.3, 136.5, 147.2, 153.1,
155.1 ppm; νmax (CHCl3): 1585, 1560, 1527, 1442 cm
–1; m/z: 409
(M+). Found: C, 64.69; H, 5.59; N, 10.29 %. Calc. for C22H23N3OS2
(409); C, 64.52; H, 5.66; N, 10.26 %).
2-Dimethylamino-6-methylsulphanyl-5-phenyl-[1,3] thiazin-
4-ylidene)-p-tolylamine (6b)
From the reaction of 5a with dimethylamine; eluent ethyl
acetate:hexane mixture (7:93, Rf = 0.65); yield 62 %; reddish
yellow solid; m.p. 182–184 °C; δH (300 MHz, CDCl3): 2.29 (s, 3H,
-CH3), 2.35 (s, 3H, -SCH3), 2.92 (s, 6H, -N (CH3)2), 6.83 (d, J 8.2 Hz,
2H, ArH), 6.97 (d, J 8.2 Hz, 2H, ArH), 7.19–7.47 ppm (m, 5H, ArH);
δC (75 MHz, CDCl3): 16.5 (-SCH3), 21.0 (-CH3), 39.9 [-N (CH3)2],
117.3, 122.3, 124.9, 127.5, 130.9, 133.1, 134.8, 135.4, 136.5, 144.8,
153.2, 155.1 ppm; νmax (CHCl3): 1588, 1408, 1330, 1114 cm
–1; m/z:
367 (M+). Found: C, 65.52; H, 5.71; N, 11.52 %. Calc. for C20H21N3S2
(367); C, 65.36; H, 5.76; N, 11.43 %).
6-Methylsulphanyl-5-phenyl-2-phenylamino-[1,3] thiazin-
4-ylidene)-p-tolylamine (6c)
From the reaction of 5a with aniline; eluent ethyl acetate:hex-
ane mixture (6:94, Rf = 0.70); yield 71 %; pale yellow solid; m.p.
129–131 °C; δH (300 MHz, CDCl3): 2.31 (s, 3H, -CH3), 2.39 (s, 3H,
-SCH3), 6.35 (bs, 1H, -NH), 6.99–7.12 (m, 4H, ArH), 7.15–7.28
(m, 5H, ArH), 7.30–7.69 ppm (m, 5H, ArH); δC (75 MHz, CDCl3):
16.3 (-SCH3), 21.0 (-CH3), 120.8, 121.1, 122.4, 123.8, 125.1, 127.2,
129.4, 131.3, 133.4, 134.6, 135.1, 136.2, 137.3, 144.5, 153.4,
155.3 ppm; νmax (CHCl3): 1598, 1571, 1527, 1485, 1330 cm
–1; m/z:
415 (M+). Found: C, 69.52; H, 5.13; N, 10.14 %. Calc. for C24H21N3S2
(415); C, 69.36; H, 5.09; N, 10.11%).
(6-Methylsulphanyl-2-morpholin-4-yl-5-phenyl-[1, 3] thiazin-
4-ylidene)-phenylamine (6d)
From the reaction of 5b with morpholine; eluent ethyl acetate:
hexane mixture (5:95, Rf = 0.64); yield 67 %; light yellow solid;
m.p. 151–152 °C; δH (300 MHz, CDCl3): 2.34 (s, 3H, -SCH3),
3.55–3.58 (m, 4H, H2C-N-CH2), 3.63–3.68 (m, 4H, H2C-O-CH2),
6.78–7.19 (m, 5H, ArH), 7.23–7.46 ppm (m, 5H, ArH); δC (75 MHz,
CDCl3): 16.4 (-SCH3), 45.6 (-C-N-C-), 66.2 (-C-O-C-), 119.2, 121.5,
125.3, 127.3, 130.1, 131.8, 132.6, 135.9, 136.8, 146.8, 152.9,
155.2 ppm; νmax (CHCl3): 1583, 1559, 1527, 1442 cm
–1; m/z: 395
(M+). Found: C, 63.69; H, 5.52; N, 10.59 %. Calc. for C21H21N3OS2
(395); C, 63.77; H, 5.35; N, 10.62 %).
2-Dimethylamino-6-methylsulphanyl-5-phenyl-[1,3] thiazin-
4-ylidene)-phenylamine (6e)
From the reaction of 5b with dimethylamine; eluent ethyl
acetate:hexane mixture (8:92, Rf = 0.66); yield 67 %; reddish
crystalline solid; m.p. 178–179 °C; δH (300 MHz, CDCl3): 2.35 (s,
3H, -SCH3), 2.91 (s, 6H, -N (CH3)2, 6.88–7.15 (m, 7H, ArH),
7.21–7.38 ppm (m, 3H, ArH); δC (75 MHz, CDCl3): 16.5 (-SCH3),
40.1[(-N (CH3)2], 115.2, 121.3, 125.4, 126.3, 131.2, 132.6, 133.1,
135.4, 136.1, 144.7, 151.8, 154.9 ppm; νmax (CHCl3): 1589, 1485,
1407, 1330 cm–1; m/z: 353 (M+). Found: C, 64.68; H, 5.46;




From the reaction of 5b with aniline; eluent ethyl acetate:hex-
ane mixture (5:95, Rf = 0.78); yield 62 %; light yellow solid; m.p.
154–155 °C; δH (300 MHz, CDCl3): 2.38 (s, 3H, -SCH3), 6.38 (bs, 1H,
-NH), 6.88–7.21 (m, 6H, ArH), 7.23–7.52 ppm (m, 9H, ArH);
δC (75 MHz, CDCl3): 16.5 (-SCH3), 120.7, 121.2, 122.4, 123.7, 125.2,
127.1, 129.4, 130.9, 134.1, 134.7, 135.5, 135.9, 137.1, 145.1, 153.1,
155.2 ppm; νmax (CHCl3): 1596, 1527, 1485, 1408, 1330 cm
–1; m/z:
401 (M+). Found: C, 68.91; H, 4.69; N, 10.41 %. Calc. for C23H19N3S2
(401); C, 68.80; H, 4.77; N, 10.46 %).
3.4. Procedure for the Synthesis of 15, 16 and 17 from
Glycine Methyl Ester 14
To a suspension of NaH (11 mmol) in DMF (40 mL) at 0 °C was
added a solution of glycine methyl ester (10 mmol) in DMF
(10 mL) and stirred for 5 min, followed by addition of carbon
disulphide (11 mmol). After stirring for an additional 10 min at
the same temperature, methyl iodide (10 mmol) was added to
the reaction mixture and the stirring continued for 30 min. On
completion, the reaction mixture was washed with an excess of
water (100 mL) and extracted using toluene. The crude product
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obtained after removal of the solvent under reduced pressure
was purified using silica gel column chromatography. The solid
compound (15) thus obtained was recrystallized from hex-
ane:ethyl acetate (5:1) mixture. For the synthesis of compounds
16 and 17, the same procedure as described above was used
using NaH (42 mmol), carbon disulphide (21 mmol), methyl/
ethyl iodide (40 mmol) for 16 and methyl iodide (40 mmol) for 17
keeping the reaction temperature at –20 °C and –78 °C, respec-
tively. The solid compounds were further recrystallized using
hexane:ethyl acetate (5:1) mixture.
For 16a, a solution of 17 (10 mmol) and iodine (10 mmol) was
refluxed in tetrahydrofuran (50 mL) for a period of 30 min. The
completion of reaction was monitored by TLC and the crude
product obtained after removal of the solvent was purified using
silica gel column chromatography. The solid compound was
further recrystallized using hexane:ethyl acetate (8:1) mixture.
Methylsulphanylthiocarbonylaminoacetic acid ethyl ester (15)
From the reaction of glycine methyl ester 14 with CS2 and
methyl iodide at 0 °C; eluent ethyl acetate:hexane mixture (4:96,
Rf = 0.80); yield 76 %; light brown solid; m.p. 109–110 °C; δH
(300 MHz, CDCl3): 2.57 (s, 3H, SCH3), 3.75 (s, 3H, -OCH3),
4.42 ppm (s, 2H, -CH2); δC (75 MHz, CDCl3): 17.5 (-SCH3), 42.5
(-CH2), 52.2 (-OCH3), 163.5, 198.9 ppm; νmax (CHCl3): 1688, 1478,
1332 cm–1; m/z: 179 (M+). Found: C, 33.88; H, 4.88; N, 7.67 %. Calc.
for C5H9NO2S2 (179); C, 33.50; H, 5.06; N, 7.81 %).
2,5-Bis-methylsulphanyl-thiazole-4-carboxylic acid
methyl ester (16a)
From the reaction of glycine methyl ester 14 with CS2 and
methyl iodide at –20 °C; eluent ethyl acetate:hexane mixture
(20:80, Rf = 0.41); yield 68 %; pale white solid; m.p. 85–86 °C; δH
(300 MHz, CDCl3): 2.56 (s, 3H, -SCH3), 2.68 (s, 3H, -SCH3),
3.91 ppm (s, 3H, -OCH3); δC (75 MHz, CDCl3): 17.0 (-SCH3), 20.1
(-SCH3), 52.2 (-OCH3), 138.2, 148.6, 161.7, 162.2 ppm; νmax (CHCl3):
1687, 1482, 1328, 1054 cm–1; m/z: 235 (M+). Found: C, 36.01;




From the reaction of glycine methyl ester 14 with CS2 and ethyl
iodide at –20 °C; eluent ethyl acetate:hexane mixture (25:75,
Rf = 0.40); yield 62 %; colourless solid; m.p. 95–96 °C; δH
(300 MHz, CDCl3): 1.29 [t, J 7.5 Hz, 6H, 2x (-S-C-CH3)], 2.99 [q,
J 7.5 Hz, 4H, 2x (-SCH2)], 3.90 ppm (s, 3H, -OCH3); δC (75 MHz,
CDCl3): 14.1 [2x (-S-C-CH3)], 25.9 [2x (-S-CH2)], 54.2 (-OCH3),
138.5, 148.3, 162.2, 163.1 ppm; νmax (CHCl3): 1688, 1330, 1054 cm
–1;
m/z: 263 (M+). Found: C, 40.97; H, 4.88; N, 5.40 %. Calc. for
C9H13NO2S3 (263); C, 41.04; H, 4.97; N, 5.32 %).
1,1,4,4-Tetramethylsulphanyl-3-methoxycarbonyl-2-aza-
1,3-butadiene (17)
From the reaction of glycine methyl ester 14 with CS2 and
methyl iodide at –78 °C; eluent ethyl acetate:hexane mixture
(40:60, Rf = 0.36); yield 72 %; light yellow solid; m.p. 75–76 °C; δH
(300 MHz, CDCl3): 2.30 (s, 3H, -SCH3), 2.32 (s, 3H, -SCH3), 2.52
(s, 6H, 2x-SCH3), 3.75 ppm (s, 3H, -OCH3); δC (75 MHz, CDCl3):
14.8 (-SCH3), 15.7 (-SCH3), 18.0 (2x-SCH3), 51.3 (-OCH3), 128.7,
139.5, 162.6, 166.0 ppm; νmax (CHCl3): 1698, 1481, 1039, 785 cm
–1;
m/z: 297 (M+). Found: C, 36.44; H, 4.94; N, 4.82 %. Calc. for
C9H15NO2S4 (297); C, 36.34; H, 5.08; N, 4.71 %).
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